Finoriq research workspace
DANAHER CORP /DE/ (DHR) SEC Filings & Filing Highlights
Danaher Corporation designs, manufactures, and markets professional, medical, research. Review DHR SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
- Company
- DANAHER CORP /DE/ (DHR)
- Ticker
- DHR
- Market Cap
- $143B
- Latest Price
- $201.99
- Industry
- Industrial Machinery
DANAHER CORP /DE/ (DHR) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for DANAHER CORP /DE/ (DHR).
| Event | Form | Date |
|---|---|---|
| Dated: June 3, 2026On June 3, 2026, Danaher Corporation, a Delaware corporation (the “Company”), and its wholly owned subsidiary DH Masi Finance Inc., a Delaw... | 8-K8.01 | 2026-06-03 |
| Debt or FinancingDebt or Financing | 8-K2.03 | 2026-06-03 |
| The Company’s annual meeting of shareholders was held on May 5, 2026. At the annual meeting, th...The Company’s annual meeting of shareholders was held on May 5, 2026. At the annual meeting, the Company’s shareholders voted on the follow... | 8-K5.07 | 2026-05-07 |
| On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corpora...On May 5, 2026, at the annual meeting of shareholders (the “Annual Meeting”) of Danaher Corporation (the “Company”), as further described i... | 8-K5.02 | 2026-05-07 |
| DANAHER CORP /DE/: Corporate updateThe Notes were sold pursuant to the terms of an underwriting agreement, dated April 22, 2026 (the “Underwriting Agreement”), among Danaher... | 8-K8.01 | 2026-04-29 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.